week 1 Flashcards

1
Q

Cmax

A

maximum (peak) plasma drug conc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tmax

A

time to reach Cmax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when taking a drug you may go above minimum effective concentration

A

MEC. you get desired effect. eventually it will fall below the MEC. pharmacological benefit is gone, but some drug may still be there.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

minimum effective concentration for adverse reactions

A

drug acts on specific targets that are beneficial in some parts of the body and dangerous in others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

after multiple doses of a drug

A

The amount of drug administered exactly replaces the amount of drug eliminated. When this occurs the drug is said to be at steady state. show same peak every single time they take the dose. they dont have any remaining from previous dose. need 4-5 half lives to achieve steady state.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

steady state concentration, Css

A

Average concentration of steady state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

once absorption occurs,

A

the free drug has been able to pass into the plasma where it may encounter proteins to which it may bind or unbind in the blood. Sometimes these proteins have the ability to carry the drugs, sometimes they do not.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

unbound

A

drug can diffuse across other cell membranes and get through barriers and enter diff tissues more readily. has to interact with some sort of receptor.
one of the receptors may help to drive pharmacological benefit/efficacious benefit
another receptor may drive an undesirable side effect (toxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

distribution

A

the drug will flow into diff tissues. The free drug may bind or unbind to diff factors in that tissue compartment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how fast can the body remove the active drug from circulation?

A

metabolism- drug remains in body but converted to another form
excretion - filtered in kidneys or excreted in bile and removed from body through poopies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

biopharmaceuticals

A

– Examines properties of the drug, dosage form, and route of administration on the rate and extent of systemic drug absorption
• stability
• release
• rate of dissolution
• systemic absorption
Goal
– develop drug products with optimal and predictable drug absorption characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

pharmacokinetics

A

– science of quantifying the amount and time course of a drug within the body
– characterization of absorption, distribution, metabolism, excretion (ADME)
– “What the body does to the drug”
•Goal
– control the amount of drug exposure at the site of drug action (effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pharmacodynamics

A

– the relationship between drug concentration at the site of activity (receptor) and effects (i.e. intensity and time course) including both efficacy and toxic
– “What the drug does to the body”
Goal
– control drug response by understanding the concentration effect relationship and establishing appropriate therapeutic targets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

important PD parameters

onset of action

A

mainly determined by rate of drug absorption, i.e. rapid absorption produces a short onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

important PD parameters

duration of action

A

determined by rate of drug elimination, therefore drug with a short half-life may have a short duration of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

important PD parameters

intensity (magnitude) of effect

A

often proportional to plasma drug concentration, i.e., Cmax and AUC

17
Q

the pharmacodynamic, for a desirable output is related to

A

the plasma concentration of the drug

18
Q

phenytoin

A

people with a lot of variability. extreme differences in pharmacokinetics bw patients. therapeutic drug monitoring is required

19
Q

experimental methods

A

• drug concentrations in biological samples are determined by analytical methods

20
Q

assays need to be

A

– sensitive- measure drug at low concentrations
– specific- distinguish drug from other interference
– precise- provide accuracy and reproducibility

21
Q

PK depends on sample measured

A

• drugs act on targets in tissues
• as a proxy for tissue concentration the following may be used
– plasma - whole blood has been obtained in the prescence of something that inhibits clotting. typically heparin, or edta
– serum (-clotting factors) - (allows blood to clot and then centrifuge it, removes RBC and WBC and clotting factors and any drug that is bound to the clotting factors)
– whole blood (RBCs, WBCs)
• drug in blood samples may be free or bound to proteins

22
Q

what are the applications for PK?

A
  • design dosage regimen (how much, how often) that maximizes therapy while minimizes side effects
  • clarifies the relationship bw therapeutic and toxic responses at different regimens
  • adjust drug dosage regimen using therapeutic drug monitoring (TDM)
  • “Population Pharmacokinetics”
  • establish bioequivalence i.e., to check whether different formulations will produce the same plasma drug concentrations or not, and therefore will produce similar therapeutic effects
23
Q

semi graph log paper

A

you never go to zero (y axis). get a ruler and there should be points above and below the line.

24
Q

digoxin once daily administration suffices

A

stable, little lost each day. morphine is eliminated very rapidly from the body, given more frequently.